Headache & Pain
Headache associated with intracranial neoplasms
Sep. 30, 2024
Worddefinition
At vero eos et accusamus et iusto odio dignissimos ducimus qui blanditiis praesentium voluptatum deleniti atque corrupti quos dolores et quas.
Acute headache: diagnosis …
- Updated 08.12.2023
- Released 10.21.2004
- Expires For CME 08.12.2026
Acute headache: diagnosis
Introduction
Overview
Headache is a common chief complaint in acute settings. The diagnosis of acute headache can be challenging and should proceed in an orderly fashion. An important first step is to distinguish primary from secondary headache disorders. The approach is to seek “red flags” in the history and exam that suggest the possibility of secondary headache. If red flags are identified, the clinician must entertain potential secondary diagnoses and proceed with the appropriate diagnostic investigations. In the absence of secondary headache, the clinician diagnoses a primary headache disorder.
Key points
|
• Migraine is the most common diagnosis in the evaluation of acute headache. | |
|
• Secondary causes must be ruled out in all cases of acute headache presentation, mainly based on “red flags” uncovered in the history and physical/neurologic examination. | |
|
• A systematic approach to the headache, characterizing it in terms of duration, quality, location, and accompanying symptoms, speeds the diagnosis. |
Headache classification
Headache is a common type of recurrent pain and one of the most frequent symptoms in medicine. Although virtually everyone experiences some kind of headache in their lifetime, there are well-defined headache disorders (defined as recurrent attacks of a particular phenotype) that vary in incidence, prevalence, and duration (34).
Before 1988, the headache classification systems that were available did not have clear operational rules, and nomenclature varied widely. In 1988, the International Headache Society instituted a classification system that has become the standard for headache diagnosis as well as clinical research (19). The 2nd edition of the International Classification of Headache Disorders (ICHD-2) was released in September of 2004 (20), and the 3rd edition (ICHD-3 beta) was issued in July 2013 in beta form (21) and finalized and published as the 3rd edition (ICHD-3) in January 2018 (22). According to this system, headache is divided into two broad categories: primary headache disorders and secondary headache disorders. In secondary disorders, headache is attributed to another condition, such as a brain tumor, infection, or head injury; for the primary disorders, no specific cause can be found.
Headache is the fifth most common chief complaint in the emergency department in about 2% of patients, or two million visits annually in the United States (27). Internists and neurologists are often called to evaluate patients during a headache attack. The diagnosis of acute headache can be challenging and should proceed in an orderly fashion. Crucial elements include a thorough history, supplemented by general medical and neurologic examinations, and laboratory testing and neuroimaging of selected patients (33).
Approaching a patient with acute headache
An important first step in acute headache diagnosis is to distinguish a primary from a secondary headache. Most patients who have an acute headache have a primary headache disorder, but the probability of secondary headache increases in the emergency department or urgent medical setting.
Certain “red flags” suggest the possibility of secondary headache. Once these features are identified, the physician must conduct the workup indicated by the red flag (Table 1) and diagnose the secondary headache disorder if one is present.
Table 1. Red Flags in the Diagnosis of Headache
|
Red flag |
Consider |
Possible investigations |
|
Sudden-onset headache (“thunderclap headache”) |
• Subarachnoid hemorrhage, first and foremost |
• Neuroimaging |
|
Worsening headache pattern |
• Mass lesion |
• Neuroimaging |
|
Headache with cancer, HIV, or other systemic illness (fever, neck stiffness, cutaneous rash) |
• Meningitis |
• Neuroimaging |
|
Focal neurologic signs or symptoms other than typical visual or sensory aura |
• Mass lesion |
• Neuroimaging |
|
Papilledema |
• Mass lesion |
• Neuroimaging |
|
Triggered by cough, exertion, or Valsalva |
• Subarachnoid hemorrhage |
• Neuroimaging |
|
Headache during pregnancy or postpartum |
• Cortical vein or cranial sinus thrombosis |
• Neuroimaging |
|
|
Table 2. Differential Diagnoses of Thunderclap Headache
|
Vascular etiologies | |
|
Subarachnoid hemorrhage | |
|
Nonvascular etiologies | |
|
Spontaneous intracranial hypotension/hypovolemia | |
Identifying secondary headache disorders
Red flags indicate an increased probability of secondary headache. The presence of a red flag increases the need to perform further investigation, but the patient must be evaluated in the context of the overall clinical picture. Certain “comfort signs,” such as acknowledgement of a typical headache trigger, a family history of similar headache attacks, or the presence of typical signs and symptoms of a primary headache disorder may offset minor red flags. Some clinical scenarios may prompt the clinician to ascribe a secondary diagnosis erroneously, leading to incorrect treatment.
(1) Sudden onset of severe headache (thunderclap headache). The sudden onset of a severe (explosive) headache must be investigated. Though the majority of patients with thunderclap headache will be ultimately diagnosed with a benign headache or non-serious intracranial pathology, about 10% of patients will have a serious intracranial pathology (35). All patients with thunderclap headache should have an expedient and exhaustive search for an underlying cause. These include serious intracranial vascular disorders, such as subarachnoid hemorrhage, intracerebral hemorrhage, cerebral venous sinus thrombosis, arteriovenous malformation, arterial dissection (intra- and extracranial), CNS angiitis, pituitary apoplexy, and reversible cerebral vasoconstriction syndrome (38). Other organic causes of thunderclap headache are colloid cysts of the third ventricle, CSF hypotension, acute sinusitis (particularly with barotrauma), and meningoencephalitis (08).
Although it is an uncommon cause of thunderclap headache, subarachnoid hemorrhage is the most feared and accounts for 7% to 25% of patients presenting with thunderclap headache (24). Thunderclap headache is actually a poor predictor of subarachnoid hemorrhage (31). Other studies have identified the following features as predictive of subarachnoid hemorrhage: age greater than 40, witnessed loss of consciousness, neck stiffness, onset during exertion, vomiting, blood pressure greater than 160/100, and arrival by ambulance (31).
A thunderclap headache evaluation should include head CT and a lumbar puncture if the CT is negative to evaluate for subarachnoid hemorrhage first and foremost. CT scan is most sensitive if performed within the first six hours of symptom onset; however, sensitivity falls as CT imaging is prolonged from initial symptom onset (02). If these studies are unrevealing, many clinicians will then order an MRA or CTA in an effort to discover an aneurysm if suspicion remains high, especially within 12 hours of ictus. In neurologically intact patients who are imaged within six hours of the onset of thunderclap headache, a noncontrast head CT is sufficient to rule out subarachnoid hemorrhage (08). If more than six hours have passed, further workup with an LP and possibly CTA is necessary. A mathematical analysis suggested that a follow-up lumbar puncture is highly cost-effective, but that CTA is questionable in this regard with no clearly defined utility (25).
If no aneurysm is revealed, or if a different etiology is highly suspected based on the presentation, other studies are warranted. When considering cerebral venous sinus thrombosis, CT is often inadequate for diagnosing it, and MRV or CTV is necessary to exclude this entity. When pituitary apoplexy is suspected, dedicated views of the sella turcica should be requested. Reversible cerebral vasoconstriction syndrome may be the cause of concern, particularly with recurrent thunderclap headache, but it is difficult to diagnose as it is an intermittent phenomenon and patients may have normal imaging early in the course. Serial arterial imaging (ie, MRA, CTA, or conventional angiography) may be required to detect it because it can be an intermittent phenomenon that also may not be visible on imaging performed early in the course (40).
When a patient with a thunderclap headache has a completely negative work-up, a diagnosis of primary thunderclap headache may be given.
(2) Worsening headache pattern. A worsening headache pattern must be interpreted in the context of a patient’s overall headache history. Headache of recent onset may indicate a mass lesion, such as a brain tumor, abscess, or subdural hematoma. Although mass lesions often present with focal neurologic deficits or papilledema, these features may be absent, particularly if the mass lesion is slow-growing or in a silent area. In this context, neuroimaging is mandatory.
When progression occurs in the context of a well-established primary disorder, two possibilities exist. Progression may represent the development of a new headache disorder (either primary or secondary) superimposed on a preexisting primary headache. Alternatively, progression may represent the evolution of a primary preexisting headache disorder. If these possibilities cannot be differentiated clinically, investigation is necessary.
Migraine and tension-type headache are well known to progress. Migraine may evolve to a condition known as chronic migraine, in which headache attacks (not necessarily migraine attacks) occur 15 or more days per month (or 180 or more days per year) with an average duration of four or more hours per day. Individuals with chronic migraine usually report a process of chronification over months or years, characterized by increasing headache frequency (43). Although chronic migraine affects 0.5% to 5% of the global population, it accounts for substantial healthcare resource utilization and overall cost (01).
Risk factors for the development of chronic migraine include high frequency of headache prior to transformation, obesity, stressful life events, alcohol overuse, hypothyroidism, viral infections, head trauma, snoring, and sleep disturbances. Overuse of acute medications is a substantial complicating factor and is now considered a sequela of comorbid phenomenon to chronic migraine (01).
A gradual progression of headache in a person with migraine who has readily identifiable exacerbating factors and a normal examination is most likely chronic migraine. Patients who have atypical clinical features or exacerbating factors that cannot be identified easily require further investigation.
(3) Headache with systemic illness or systemic symptoms. Many systemic disorders are associated with a prominent complaint of acute headache.
Table 3. Systemic Diseases Associated with Headache
Gastrointestinal Disorders | |
- Inflammatory bowel disease | |
Cardiovascular Disorders | |
- Hypertensive urgency | |
Obstetrical/Gynecological | |
- Pre-eclampsia | |
Pulmonary Disorders | |
- Sleep apnea | |
Metabolic/Endocrine Disorders | |
- Hyperthyroidism | |
Rheumatologic Disorders | |
- Systemic lupus erythematosus | |
Hematological Disorders | |
- Iron deficiency anemia | |
Infectious Etiologies | |
- Meningitis | |
| |
Clues that the headache is associated with a systemic illness include systemic symptoms, such as fever, neck stiffness, cutaneous rash, fatigue, malaise, and arthralgias. A skin rash could suggest Lyme disease (erythema migrans), herpes zoster (vesicles distributed in a dermatomal pattern), or sarcoidosis (erythema nodosum). Other dermatologic disorders might suggest the presence of a systemic or localized disease, such as antiphospholipid antibody syndrome or Sneddon syndrome. A clinician should search for opportunistic infections (including toxoplasmosis and cryptococcal meningitis) and malignancy in patients who have AIDS or HIV risk factors and in those who are immunocompromised.
Headache occurs in 11% to 34% of patients hospitalized with COVID-19. In patients with a preexisting migraine disorder, severe persistent headache may be an early symptom of infection. Persistent headache following COVID-19 infection is a common symptom of the “long COVID” syndrome (09).
In patients with cancer, brain and leptomeningeal metastasis should be considered. Depending on the clinical setting, blood work, neuroimaging, and CSF examination may be required.
(4) Headache with focal signs other than typical visual or sensory aura. Aura is most commonly associated with migraine but also may occur with other primary headache disorders (eg, chronic paroxysmal hemicrania, cluster headache, and tension-type headache) (22). Typical migraine aura is rarely associated with secondary causes.
Focal signs other than aura are divided into those that are transient and those that are permanent. Transient focal signs may be the manifestations of seizure, transient ischemic attack, and toxic-metabolic disorders. Permanent deficits (even those that are partial and difficult to detect unequivocally) may be caused by stroke, mass lesion, arteriovenous malformation, or connective tissue disorders. Appropriate workup includes neuroimaging, rheumatologic evaluation, and sometimes lumbar puncture.
Differentiating aura related to headache from a simple partial seizure may be difficult. Table 4 describes clinical clues that are useful in establishing this differentiation. If seizure is suspected, EEG and neuroimaging (in patients who have not been previously investigated) are required. Migraine and epilepsy may be comorbid, and individuals with epilepsy are more likely to experience migraine than those without. Headaches are usually temporally unrelated to seizures but may occur before, during, or shortly after a seizure (04). In patients with both disorders, careful history-taking should differentiate between a migraine aura and a seizure, ensuring that the patient’s treatment plan is appropriately tailored according to their migraine frequency and seizure frequency.
Table 4. The Aura in Migraine and Epilepsy
Symptom | Migraine | Epilepsy |
Duration of aura | 15 to 60 minutes | Brief, often--shorter than 1 min |
Automatisms | Unusual | Frequent for focal onset seizures |
Gastrointestinal aura | Abdominal pain (rare); | "Butterflies"--rising epigastric sensation |
Visual disturbances | Positive or negative | Complicated visual phenomenon |
Paresthesias | Common (5 to 60 minutes) | Common (seconds to minutes) |
Altered consciousness | Usually responsive | Often unresponsive |
Olfactory | Very uncommon | More common |
Aphasia | Common | Common |
Déjà vu | Rare | Common |
| ||
(5) Headache triggered by cough, exertion, orgasm, or Valsalva. The key issue in establishing this red flag is to identify the sudden development of a headache temporally related to a trigger. Headache unequivocally triggered by cough, heavy exercise, or orgasm must be investigated with neuroimaging (03). A headache triggered by straining, coughing, or sneezing suggests a hindbrain malformation, occipitocervical junction disorder (including Arnold-Chiari malformation), increased intracranial pressure, or vasospasm. If no secondary cause is identified, the diagnosis of a primary triggered headache may be given.
(6) Headache during pregnancy or postpartum. Most headache that occurs during pregnancy or postpartum are migraine or tension-type headache. In a pregnant or postpartum woman with a history of migraine or tension-type headache, without atypical features and with a normal examination, investigation is usually not necessary. However, some women report new onset of severe headache with migraine features, or a worsening pattern of a previously diagnosed primary headache. In these cases, intracranial hypertension or hypotension, cortical vein or cranial sinus thrombosis, carotid dissection, reversible cerebral vasoconstriction syndrome, and pituitary apoplexy enter into the differential diagnosis, especially in the proper clinical context (29). These disorders are much more common in the third trimester or in the early postpartum period. Stroke is thought to be more common in late pregnancy and the early postpartum period. Neuroimaging, including MRI and MRA, is necessary to exclude such vascular disorders. The differential diagnosis also includes preeclampsia, a multi-system disorder with various forms. In addition to hypertension and proteinuria, tissue edema, thrombocytopenia, and abnormalities in liver function can occur. Preeclampsia appears to involve a strong maternal inflammatory response with broad systemic activity. Subsidiary investigation includes blood and urine testing (12).
(7) Positional headache. Orthostatic or reverse-orthostatic headache may result from dysregulation of cerebrospinal fluid pressure or volume. Though orthostatic headache is typically due to low pressure/volume, and reverse-orthostatic headache can be due to elevated pressure/volume, the opposite may also be true. In fact, elevated pressure/volume usually does not present with positional headache, but rather with visual obscurations, pulsatile tinnitus, and papilledema, with variable but commonly migrainous headache quality (26). The diagnosis of a low pressure/volume state is suggested not only by orthostatic headache, but also by “second-half-of-the-day headache.” Migraine features are common, and if significant hindbrain descent occurs, cerebellar and brainstem signs and symptoms may be present. MRI with gadolinium may show “brain sag,” pituitary engorgement, and pachymeningeal enhancement, and MRV may show the “venous distention sign” of a convex appearance to the transverse sinuses on sagittal view. Some orthostatic headache syndromes are due to slow, undetectable leaks or result from increased compliance of the lower lumbar CSF space without actual leak (11). Spinal CSF leaks, traditionally difficult to detect, are increasingly recognized as a cause of orthostatic headache, with some leaks having the etiology of a CSF-venous fistula (37). Other orthostatic headache syndromes are not due to CSF pressure dysregulation at all, but rather to autonomic dysfunction in disorders such as orthostatic hypotension and postural orthostatic tachycardia syndrome (10). Another potential cause is cervicogenic headache, particularly in hypermobility syndrome and atlanto-axial instability syndrome. Orthostatic headache may also be reflective of vestibular pathology, particularly in the presence of vertigo, nystagmus, and other positional triggers.
(8) Headache in the elderly. Headache in this age group should always be investigated for secondary cause, although primary headache syndromes do occur (eg, hypnic headache). Giant cell arteritis is an underdiagnosed and preventable cause of visual loss and stroke in the elderly. When giant cell arteritis is suspected (headache, constitutional signs and symptoms, jaw claudication, temporal artery tenderness, transient neurologic symptoms, etc.), empiric treatment with steroids is justified and mandatory while awaiting the results of laboratory investigations and biopsies of the temporal arteries. The workup usually includes a complete blood cell count with differentiation, sedimentation rate, and C-reactive protein, and there is evidence that temporal artery ultrasound, MRI, and PET scans may complement or sometimes even replace biopsy in some cases (13).
Headache in the elderly associated with activity may be an anginal equivalent, a rare disorder sometimes termed “cardiac cephalalgia” (36). Other common diagnostic considerations are cervicogenic headache from severe degenerative disease, metastatic cancer, and subdural hemorrhage; these are usually suggested by typical history and examination findings.
(9) Sinus symptoms and headache. The interplay of sinus symptoms and migraine is a complex relationship and can pose challenges in diagnosis and treatment (07). Congestion, rhinorrhea, aural fullness, and facial pain may occur in primary headache disorders (migraine, tension-type, and trigeminal autonomic cephalalgias), often leading to a misdiagnosis of “sinus headaches” (06). In one series, only 5% of suspected sinus headaches actually met criteria for this diagnosis (acute sinus infection with headache that resolves after appropriate antimicrobial therapy), leading to inappropriate treatment with antibiotics in a vast majority, sinus endoscopy in about a quarter, and even septoplasty in about 15% (17). A diagnosis that is not to be missed is sphenoid sinusitis, an elusive entity due to the general lack of obvious sinus symptoms. Untreated, it can lead to significant morbidity. Fever and cranial nerve abnormalities (optic, oculomotor, trigeminal) may be seen. Neuroimaging is necessary to make this diagnosis as diagnostic nasal endoscopy may be negative in some patients (06).
(10) The eye and headache. Most ophthalmologic disorders in which a symptom of headache is common are readily diagnosed based on the obvious abnormal physical manifestations typical of these problems. However, these signs may be absent or easily overlooked, as in acute angle closure glaucoma; therefore, one must maintain clinical suspicion in order to arrive at the correct diagnosis. Some other examples of ocular disorders that may not have obvious physical abnormalities are dry eye, keratitis, uveitis, and trochleitis (18). Not all headache accompanied by abnormal physical appearance of the eye is ophthalmologic in nature, of course, with the trigeminal autonomic cephalalgias being the best example (see below).
Diagnosing a primary headache disorder
In the absence of secondary causes or contributors, the clinician can proceed to diagnosing a primary headache disorder. If the headache is atypical or difficult to classify, the possibility of secondary headache should be reconsidered, although the modifying effect of any treatment should be kept in mind. Discussing the diagnostic criteria of primary headache disorders is beyond the scope of this article. The objective of this section is to propose a strategy to approach the primary headache disorders, after excluding secondary disorders.
If a patient has acute headache and secondary headache syndromes have been excluded, the next step is to assign the primary headache diagnosis. Patients can be divided into those whose headache occurs at low-to-moderate frequency (fewer than 15 headache days per month) versus high frequency (15 or more headache days per month). Based on average duration of a typical untreated headache attack, the headache syndrome is classified as either short-duration (less than 4 hours a day) or long-duration (4 or more hours) (22).
Low-to-moderate frequency headache attacks of long duration
Low-to-moderate frequency headache attacks of long duration include episodic migraine and episodic tension-type headache. The main pain features of tension-type headache are bilateral location, non-pulsating quality, mild to moderate intensity, and lack of aggravation by routine physical activity. The pain is not accompanied by nausea or vomiting, although either photophobia or phonophobia (but not both) may occur (22). Even though episodic tension-type headache is the most prevalent primary headache disorder in the population, it is not a frequent reason for medical consultation.
Migraine is the most common acute headache disorder seen in the emergency department, by far more frequent than secondary headache syndromes (33). Migraine attacks in the acute care setting are usually severe, throbbing, and associated with nausea, photophobia, or phonophobia. If the attack is very severe, the patient may be prostrate and pale, sometimes vomiting. Although unilaterality of pain is a diagnostic criterion, pain is often bilateral. It is not necessary to investigate a typical attack. However, migraine-like attacks not responsive to treatment and requiring prolonged observation (longer than 12 hours) should be investigated further.
Presentations other than typical migraine with or without aura are more common in the emergency department than in other settings. Migraine with brainstem aura is a subtype characterized by at least two of the following aura symptoms, all fully reversible: dysarthria, vertigo, tinnitus, decreased hearing, double vision, ataxia, and decreased level of consciousness. The attack otherwise fulfills criteria for migraine (22).
Hemiplegic migraine is the first migraine syndrome to be linked to a specific set of genetic polymorphisms (14). Patients experience aura that includes motor weakness (hemiplegia) and may be more prolonged than 60 minutes (up to 24 hours). In familial hemiplegic migraine, at least one first-degree relative has had similar attacks (also meeting these criteria). Cerebellar ataxia occurs in 20% of familial hemiplegic migraine cases. Headache syndromes that otherwise meet these criteria but present without family history of the disorder are classified as sporadic hemiplegic migraine. Unless patients already have a diagnosis of hemiplegic migraine (and were, therefore, previously investigated), additional investigation is necessary.
Status migrainosus refers to an attack of migraine with a headache phase that lasts longer than 72 hours. The pain and associated symptoms are debilitating.
Persistent aura without infarction is diagnosed when aura symptoms, otherwise typical of past attacks, persist for more than one week, and investigation shows no evidence of infarction. It is an unusual but well-documented complication of migraine that is now included in the International Headache Society classification.
Migrainous infarction is an uncommon occurrence. One or more otherwise typical aura symptoms persist beyond one hour, and neuroimaging confirms ischemic infarction. Strictly applied, these criteria distinguish this disorder from other causes of stroke, which must be excluded. The neurologic deficit develops during the course of an apparently typical attack of migraine with aura and exactly mimics the aura of previous attacks, but it persists and is proven to be due to cerebral ischemia (22).
High-frequency headache attacks of long duration
High-frequency headache attacks of long duration include chronic migraine, chronic tension-type headache, new daily persistent headache, and hemicrania continua. Medication overuse is common, being present in more than 80% of chronic migraine patients in subspecialty clinics but in only 30% of people with chronic headache in population studies (41). Patients with chronic migraine tend to seek care when they have a superimposed full-blown migraine (exacerbation). When a clear history is obtained, and the exam is unremarkable, investigation is not required.
New daily persistent headache is characterized by the abrupt onset of a chronic daily headache. It is classified as a primary headache disorder, although a viral prodrome may precede the onset, suggesting that some syndromes may actually be secondary despite the lack of an obvious demonstrable cause. When patients with acute headache first seek care with this syndrome, thorough investigation is necessary to exclude secondary disorders (44).
Hemicrania continua is commonly mistaken for chronic migraine. Both disorders are characterized by chronic unilateral pain with superimposed painful exacerbations. In hemicrania continua, the exacerbations are associated with ipsilateral autonomic features, such as conjunctival injection, lacrimation, and ptosis, though migraine features may be present as well. In chronic migraine, exacerbations are more typically accompanied by nausea, photophobia, and phonophobia, though autonomic features may occur. If the headache is longstanding, the patient may not remember how the problem began. Though pain fluctuates in hemicrania continua, it does not usually have the morning and end-of-dosing-interval pattern of exacerbations typical of chronic migraine. It is advisable to offer patients with unilateral chronic daily headache a therapeutic trial with indomethacin (doses of up to 225 mg/day for 3 to 4 days) prior to other intervention (32).
Headache attacks of shorter duration
High-frequency, short-duration headache syndromes include the trigeminal autonomic cephalalgias (episodic and chronic cluster headache, episodic and chronic paroxysmal hemicrania), SUNCT (short lasting unilateral neuralgiform headache attacks with conjunctival injection and tearing) and SUNA (short lasting unilateral neuralgiform headache attacks with autonomic features) syndromes, hypnic headache, and exertional headache.
The trigeminal autonomic cephalalgias (TACs) are characterized by unilateral pain in the trigeminal distribution, with ipsilateral autonomic features (28). The most common disorder in this family is cluster headache. The pain of cluster headache is described variously as sharp, boring, drilling, knife-like, piercing, or stabbing, in contrast to the pulsating pain of migraine. It usually peaks in 10 to 15 minutes but remains excruciatingly intense for an average of 1 hour within a duration range of 15 to 180 minutes. During this pain, patients find it difficult to remain still, often exhibiting marked agitation and restlessness, and autonomic features are usually prominent. After an attack, the patient may be exhausted for some time. In episodic cluster, the disease is active periodically with at least three months between bouts. In the chronic form, remissions are shorter than three months or absent entirely (42).
Like cluster headache, episodic and chronic paroxysmal hemicrania are characterized by unilateral attacks of trigeminal pain and autonomic features. The paroxysmal hemicranias have three main features that distinguish from cluster headache: (1) greater frequency (more than 5 per day); (2) shorter duration (2 to 30 minutes); (3) absolute response to therapeutic doses of indomethacin. The same distinction between episodic and chronic is made as with cluster headache. Paroxysmal hemicranias are relatively rare (30).
SUNCT is another rare primary headache. The diagnostic criteria describe high-frequency attacks (3 to 200 per day) of unilateral orbital, supraorbital, or temporal stabbing or pulsating pain, lasting 5 to 240 seconds and accompanied by ipsilateral conjunctival injection and lacrimation. The attacks are characteristically dramatic, with moderate to severe pain, peaking in intensity within three seconds, and prominent tearing (15).
SUNA syndrome is similar to SUNCT. Attacks may last slightly longer and be less frequent. Either conjunctival injection or tearing may be present, but not both, and other autonomic features are more common (15). SUNCT and SUNA together comprise the short-lasting unilateral neuralgiform headache attacks (SUNHA) syndromes (22).
Hypnic headache is a primary headache disorder of the elderly, characterized by short-lived attacks (typically 30 minutes) of nocturnal head pain that awaken the patient at a consistent time each night, in many cases on more nights than not. It does not occur outside sleep. Hypnic headache is usually bilateral (although unilaterality does not exclude the diagnosis) and typically mild to moderate in intensity, different from the unilateral orbital or periorbital, knife-like, intense pain of cluster headache. Autonomic features are usually absent (39).
Headache triggered by cough, exertion, sexual activity, or external stimuli include the disorders named for these triggers. Especially in patients presenting in the emergency department, or during an attack, these headache syndromes may only be diagnosed after an exhaustive and methodical search for secondary causes. However, in a patient previously investigated or previously diagnosed, repeating the investigation is usually not necessary, and patients simply should be treated.
Conclusions
As previously discussed, the differential diagnosis of acute headache requires a systematic approach. In a 1990 review article, John Edmeads stated that even when a patient is quiet and calm, able and willing to present an orderly history, and easy to examine, the headache diagnosis may be difficult (16). However, during an attack, headache sufferers may not be completely cooperative, and, consequently, the quality of the information may be affected. We have herein presented an orderly approach to differential diagnosis. The precise criteria for each disorder are presented elsewhere (22). This outline should help clinicians move forward quickly and safely when assessing patients with acute headache.
Media
References
- 01
- Agostoni EC, Barbanti P, Calabresi P, et al. Current and emerging evidence-based treatment options in chronic migraine: a narrative review. J Headache Pain 2019;20(1):92. PMID 31470791
- 02
- Backes D, Rinkel GJ, Kemperman H, Linn FHH, Vergouwen MDI. Time-dependent test characteristics of head computed tomography in patients suspected of nontraumatic subarachnoid hemorrhage. Stroke 2012;43(8):2115-9. PMID 22821609
- 03
- Bahra A. Other primary headaches-thunderclap-cough-exertional-,and sexual headache. J Neurol 2020;267(5):1554-66. PMID 32130497
- 04
- Bauer PR, Tolner EA, Keezer MR, Ferrari MD, Sander JW. Headache in people with epilepsy. Nat Rev Neurol 2021;17(9):529-544. PMID 34312533
- 05
- Bigal ME, Lipton RB, Cohen J, Silberstein SD. Epilepsy and migraine. Epilepsy Behav 2003;4(Suppl 2):13-24. PMID 14527480
- 06
- Ceriani CEJ, Silberstein SD. Headache and rhinosinusitis: a review. Cephalalgia 2021;41(4):453-63. PMID 32954817
- 07
- Charleston L, Strabbing R, Cooper W. Is sinus disease the cause of my headaches? An update on sinus disease and headache. Curr Pain Headache Rep 2014;18(6):418. PMID 24760488
- 08
- Chen C, Fuh J. Evaluating thunderclap headache. Curr Opin Neurol 2021;34(3):356-62. PMID 33661161
- 09
- Cocores AN, Monteith TS. Headache as a neurologic manifestation of systemic disease. Curr Treat Options Neurol 2022;24(1):17-40. PMID 35317303
- 10
- Curone M, Cecchini AP, Chiapparini L, D’Amico D. Persistent orthostatic headache without intracranial hypotension: Which treatment? Neurol Sci 2015;36 Suppl 1:153-5. PMID 26017533
- 11
- D’Amico D, Usai S, Chiapparini L, et al. Headache in spontaneous intracranial hypotension: an overview with indications for differential diagnosis in the clinical practice. Neurol Sci 2020;41(Suppl 2):423-7. PMID 33034803
- 12
- de Gaalon S, Donnet A. Headaches during pregnancy. Rev Neurol 2021;177(3):195-202. PMID 32838992
- 13
- Dinkin M, Johnson E. One giant step for giant cell arteritis: updates in diagnosis and treatment. Curr Treat Options Neurol 2021;23(2):6. PMID 33488050
- 14
- Di Stefano V, Rispoli MG, Pellegrino N, et al. Diagnostic and therapeutic aspects of hemiplegic migraine. J Neurol Neurosurg Psychiatry 2020;91(7):764-71. PMID 32430436
- 15
- Duggal AK, Chowdhury D. SUNCT and SUNA: an update. Neurol India 2021;69:S144-59. PMID 34003160
- 16
- Edmeads J. Challenges in the diagnosis of acute headache. Headache 1990;30(Suppl 2):537-40. PMID 2272821
- 17
- Foroughipour M, Sharifian SM, Shoeibi A, Ebdali Barabad N, Bakhshaee M. Causes of headache in patients with a primary diagnosis of sinus headache. Eur Arch Otorhinolaryngol 2011;268(11):1593-6. PMID 21626445
- 18
- Friedman DI. The eye and headache. CONTINUUM Lifelong Learn Neurol 2015;21(4):1109-17. PMID 26252594
- 19
- Headache Classification Committee of the International Headache Society. Classification and diagnostic criteria for headache disorders, cranial neuralgias and facial pain. Cephalalgia 1988;8(Suppl 7):1-96. PMID 3048700
- 20
- Headache Classification Committee of the International Headache Society. The International Classification of Headache Disorders. Cephalalgia 2004;24:1-160.
- 21
- Headache Classification Committee of the International Headache Society (IHS). The international classification of headache disorders, 3rd edition (beta version). Cephalalgia 2013;33(9):629-808.
- 22
- Headache Classification Committee of the International Headache Society (IHS). The International Classification of Headache Disorders, 3rd edition. Cephalalgia 2018;38(1):1-211. PMID 29368949
- 23
- Lipton RB, Silberstein SD, Dodick DW. Overview, diagnosis and classification. In: Silberstein SD, Lipton RB, Dodick DW, editors. Wolff’s Headache and Other Facial Pain. New York: Oxford University Press, 2008:6-26.
- 24
- Long D, Koyfman Alex, Long B. The thunderclap headache: approach and management in the emergency department. J Emerg Med 2019;56(6):633-41. PMID 30879843
- 25
- Malhotra A, Wu X, Kalra VB, Schindler J, Forman HP. Cost-effectiveness analysis of follow-up strategies for thunderclap headache patients with negative noncontrast CT. Acad Emerg Med 2016;23(3):243-50. PMID 26728524
- 26
- Mollan SP, Grech O, Sinclair AJ. Headache attributed to idiopathic intracranial hypertension and persistent post-idiopathic intracranial hypertension headache: a narrative review. Headache 2021;61(6):808-16. PMID 34106464
- 27
- Munoz-Ceron J, Marin-Careaga V, Peña L, Mutis J, Ortiz G. Headache at the emergency room: Etiologies, diagnostic usefulness of the ICHD 3 criteria, red and green flags. PLoS ONE 2019;14(1):e0208728.** PMID 30615622
- 28
- Nahas SJ. Cluster headache and other trigeminal autonomic cephalalgias. Continuum (Minneap Minn) 2021;27(3):633-51. PMID 34048396
- 29
- O’Neal MA. Headaches complicating pregnancy and the postpartum period. Pract Neurol 2017;17(3):191-202. PMID 28473606
- 30
- Paliwal VK, Uniyal R. Paroxysmal hemicrania: an update. Neurol India 2021;69:S135-43. PMID 34003159
- 31
- Perry JJ, Stiell IG, Sivilotti ML, et al. Clinical decision rules to rule out subarachnoid hemorrhage for acute headache. JAMA 2013;310(12):1248-55. PMID 24065011
- 32
- Prakash S, Rawat KS. Hemicrania continua: an update. Neurol India 2021;69:S160-7. PMID 34003161
- 33
- Raam R, Tabatabai RR. Headache in the emergency department: avoiding misdiagnosis of dangerous secondary causes, an update. Emerg Med Clin North Am 2021;39(1):67-85.** PMID 33218663
- 34
- Robbins MS. Diagnosis and management of headache: a review. JAMA 2021;325(18):1874-85.** PMID 33974014
- 35
- Roberts T, Horner DE, Chu K, et al. Thunderclap headache syndrome presenting to the emergency department: an institutional multicenter observational cohort study. Emerg Med J 2022;39:803-9. PMID 35144978
- 36
- Ruiz Ortiz M, Bermejo Guerrero L, Martínez Porqueras R, González de la Aleja J. Cardiac cephalgia: when myocardial ischaemia reaches the neurologist's consultation. Neurologia 2020;35(8):614-5. PMID 31780317
- 37
- Schievink WI, Maya M, Prasad RS, et al. Spontaneous spinal cerebrospinal fluid-venous fistulas in patients with orthostatic headaches and normal conventional brain and spine imaging. Headache 2021;61(2):387-91. PMID 33484155
- 38
- Sheikh HU, Mathew PG. Reversible cerebral vasoconstriction syndrome: updates and new perspectives. Curr Pain Headache Rep 2014;18(5):414. PMID 20425213
- 39
- Silva-Neto RP, Santos PEMS, Peres MFP. Hypnic headache: a review of 348 cases published from 1988 to 2018. J Neurol Sci [Internet] 2019;401:103-9. PMID 31075680
- 40
- Spadaro A, Scott KR, Koyfman A, Long B. Reversible cerebral vasoconstriction syndrome: a narrative review for emergency clinicians. Am J Emerg Med 2021;50:765-72. PMID 34879501
- 41
- Sun-Edelstein C, Rapoport AM, Rattanawong W, Srikiatkhachorn A. The evolution of medication overuse headache: history, pathophysiology and clinical update. CNS Drugs 2021;35(5):545-65. PMID 34002347
- 42
- Suri H, Ailani J. Cluster headache: a review and update in treatment. Curr Neurol Neurosci Rep 2021;21(7):31. PMID 33948734
- 43
- Torres-Ferrus M, Ursitti F, Alpuente A, et al. From transformation to chronification of migraine: pathophysiological and clinical aspects. J Headache Pain 2020;21(1):42. PMID 32349653
- 44
- Yamani N, Olesen J. New daily persistent headache: a systematic review on an enigmatic disorder. J Headache Pain 2019;20(1):80. PMID 31307396
Contributors
All contributors' financial relationships have been reviewed and mitigated to ensure that this and every other article is free from commercial bias.
Authors
-
Claire E Ceriani MD
Dr. Ceriani of Thomas Jefferson University has no relevant financial relationships to disclose.
See Profile -
Stephanie J Nahas MD
Dr. Nahas of Thomas Jefferson University received honorariums from Allergan/AbbVie, Amneal, Eli Lilly, Lundbeck, Pfizer, and Tonix as consultant.
See Profile
Editor
-
Stephen D Silberstein MD
Dr. Silberstein, Director of the Jefferson Headache Center at Thomas Jefferson University has no relevant financial relationships to disclose.
See Profile
Former Authors
- Shyam C Majmundar MD
- Richard B Lipton MD, Benjamin W Friedman MD (original authors), and Marcelo E Bigal MD PhD
This is an article preview.
Start a Free Account
to access the full version.
-
Nearly 3,000 illustrations, including video clips of neurologic disorders.
-
Every article is reviewed by our esteemed Editorial Board for accuracy and currency.
-
Full spectrum of neurology in 1,200 comprehensive articles.
-
Listen to MedLink on the go with Audio versions of each article.
Questions or Comment?
MedLink®, LLC
3525 Del Mar Heights Rd, Ste 304
San Diego, CA 92130-2122
Toll Free (U.S. + Canada): 800-452-2400
US Number: +1-619-640-4660
Support: service@medlink.com
Editor: editor@medlink.com
ISSN: 2831-9125
Also in This Category
-
-
Neuropharmacology & Neurotherapeutics
Acupuncture
Sep. 09, 2024
-
Headache & Pain
Migraine in childhood
Sep. 04, 2024
-
Headache & Pain
Headache attributed to head trauma
Aug. 28, 2024
-
Headache & Pain
Migraine: pathogenesis and pathophysiology
Aug. 24, 2024
-
Headache & Pain
Tension-type headache
Aug. 23, 2024
-
Headache & Pain
Benign paroxysmal vertigo
Aug. 23, 2024
-
Headache & Pain
Vagal nerve stimulation for headaches
Aug. 23, 2024